About
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. The company is headquartered in Los Angeles, California, and is publicly traded on NASDAQ under the ticker symbol PBYI.
Focus
Office
Lease
Markets
Headquarters
10880 Wilshire Blvd., Suite 1700
FAQs
Puma Biotechnology, Inc. has financed 1 deal.
Puma Biotechnology, Inc.'s most recent deal was on October 15, 2023.
Member since: October 2024